Deutsche Bank Ag\ Amphastar Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 23,243 shares of AMPH stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,243

Previous 18,145 28.1%

Holding current value

$1.06 Million

Previous $725,000 55.45%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$36.99 - $50.09 $188,575 - $255,358	5,098 Added 28.1%	23,243 $1.13 Million
Q2 2024 Aug 14, 2024	SELL	$38.65 - $43.48 $101,649 - $114,352	-2,630 Reduced 12.66%	18,145 $725,000
Q1 2024 May 15, 2024	SELL	$42.85 - $63.45 $424,686 - $628,852	-9,911 Reduced 32.3%	20,775 $912,000
Q4 2023 Feb 14, 2024	BUY	$44.49 - $62.93 $412,867 - $583,990	9,280 Added 43.35%	30,686 $1.9 Million
Q3 2023 Nov 09, 2023	BUY	$45.51 - $65.0 $106,538 - $152,165	2,341 Added 12.28%	21,406 $984,000
Q2 2023 Aug 14, 2023	SELL	$35.77 - $58.38 $344,286 - $561,907	-9,625 Reduced 33.55%	19,065 $1.1 Million
Q1 2023 May 15, 2023	BUY	$27.99 - $37.92 $211,184 - $286,106	7,545 Added 35.68%	28,690 $1.08 Million
Q4 2022 Feb 13, 2023	BUY	$27.93 - $31.27 $79,209 - $88,681	2,836 Added 15.49%	21,145 $592,000
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $119,279 - $163,382	-4,328 Reduced 19.12%	18,309 $515,000
Q2 2022 Aug 11, 2022	BUY	$29.79 - $42.29 $49,421 - $70,159	1,659 Added 7.91%	22,637 $787,000
Q1 2022 May 13, 2022	SELL	$22.96 - $36.45 $52,371 - $83,142	-2,281 Reduced 9.81%	20,978 $753,000
Q4 2021 Feb 11, 2022	BUY	$18.14 - $23.29 $21,441 - $27,528	1,182 Added 5.35%	23,259 $541,000
Q3 2021 Nov 04, 2021	SELL	$17.83 - $21.49 $959,253 - $1.16 Million	-53,800 Reduced 70.9%	22,077 $420,000
Q2 2021 Aug 11, 2021	BUY	$17.11 - $20.92 $547,194 - $669,042	31,981 Added 72.86%	75,877 $1.53 Million
Q1 2021 May 13, 2021	BUY	$17.21 - $20.65 $179,896 - $215,854	10,453 Added 31.26%	43,896 $804,000
Q4 2020 Feb 16, 2021	BUY	$17.76 - $21.24 $133,661 - $159,852	7,526 Added 29.04%	33,443 $672,000
Q3 2020 Nov 12, 2020	BUY	$17.99 - $22.22 $30,690 - $37,907	1,706 Added 7.05%	25,917 $486,000
Q2 2020 Aug 13, 2020	SELL	$14.25 - $22.46 $240,240 - $378,653	-16,859 Reduced 41.05%	24,211 $544,000
Q1 2020 May 14, 2020	BUY	$12.66 - $20.08 $84,923 - $134,696	6,708 Added 19.52%	41,070 $609,000
Q4 2019 Feb 14, 2020	BUY	$17.07 - $20.64 $42,675 - $51,600	2,500 Added 7.85%	34,362 $661,000
Q3 2019 Nov 14, 2019	SELL	$19.12 - $22.62 $558,017 - $660,164	-29,185 Reduced 47.81%	31,862 $630,000
Q2 2019 Aug 14, 2019	SELL	$18.92 - $22.96 $1.1 Million - $1.34 Million	-58,344 Reduced 48.87%	61,047 $1.29 Million
Q1 2019 May 15, 2019	BUY	$19.46 - $25.28 $841,392 - $1.09 Million	43,237 Added 56.78%	119,391 $2.44 Million
Q4 2018 Feb 14, 2019	SELL	$17.72 - $22.51 $911,375 - $1.16 Million	-51,432 Reduced 40.31%	76,154 $1.51 Million
Q3 2018 Dec 21, 2021	BUY	$15.39 - $19.38 $380,964 - $479,732	24,754 Added 24.07%	127,586 $2.46 Million
Q3 2018 Nov 14, 2018	SELL	$15.39 - $19.38 $1.13 Million - $1.42 Million	-73,304 Reduced 41.62%	102,832 $1.98 Million
Q2 2018 Apr 21, 2020	BUY	$14.63 - $19.6 $1.03 Million - $1.38 Million	70,514 Added 66.76%	176,136 $2.69 Million
Q2 2018 Aug 14, 2018	SELL	$14.63 - $19.6 $1.16 Million - $1.55 Million	-79,291 Reduced 42.88%	105,622 $1.61 Million
Q1 2018 Oct 18, 2019	BUY	$17.23 - $20.35 $1.78 Million - $2.1 Million	103,246 Added 126.42%	184,913 $3.47 Million
Q1 2018 May 15, 2018	SELL	$17.23 - $20.35 $494,156 - $583,638	-28,680 Reduced 25.99%	81,667 $1.53 Million
Q4 2017 Feb 14, 2018	SELL	$17.76 - $19.75 $54,558 - $60,672	-3,072 Reduced 2.71%	110,347 $2.12 Million
Q3 2017 Nov 14, 2017	BUY	$14.73 - $17.99 $1.67 Million - $2.04 Million	113,419	113,419 $2.02 Million

Others Institutions Holding AMPH

# of Institutions

287

Shares Held

35.1M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.23B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account